ELUT — ELUTIA INC.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1708527 ·
Last close
$0.85
Market Cap
$37.91M
52W High
$1.38
52W Low
$0.50
ADV30
88,367
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 2,427,000 | 1,447,000 | -5,900,000 | -7,646,000 | 43,649,000 | 19,896,000 | 27,903,000 |
| Mar 2026 | 3,114,000 | 1,802,000 | -5,742,000 | -7,469,000 | 55,209,000 | 28,488,000 | 32,682,000 |
| Dec 2025 | 3,271,000 | 1,914,000 | -5,491,000 | 70,791,000 | 62,350,000 | 36,350,000 | 34,678,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-49,234,000
Investing CF
$87,114,000
Financing CF
$-13,508,000
CapEx
$-1,446,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$1.10
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-192,613,000
Inventory
$272,000
Receivables
$11,993,000
ST Investments
—
EBIT TTM
$-23,350,000
Pretax Income TTM
$-28,478,000
Interest Exp TTM
$1,245,000
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$13,592,000
EBITDA
$-22,855,000
Free Cash Flow
$-27,474,000
Enterprise Value
$21,159,062
Total Cash
$29,093,000
Total Debt
$13,915,000
Shares Out
44,397,650
Trailing EPS
$-0.68
Book Value
$0.35
ROE
—
ROA
-36.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 12,293,000 | -18,412,000 | 53,380,000 | 62,350,000 | 34,678,000 | 27,672,000 | -44,810,000 |
| Dec 2024 | 14,467,000 | -19,344,000 | -53,949,000 | 36,127,000 | 82,387,000 | -46,260,000 | -22,657,000 |
| Dec 2023 | 24,745,000 | -20,537,000 | -37,656,000 | 43,428,000 | 82,028,000 | -38,600,000 | -21,761,000 |
| Dec 2022 | 23,849,000 | -29,989,000 | -32,897,000 | 68,841,000 | 73,874,000 | -5,033,000 | -21,434,000 |
TTM Snapshot
Revenues TTM
$5,541,000
NetIncome TTM
$51,808,000
OpCashFlow TTM
—
Assets (Latest)
$43,649,000
Forward EPS
$-1.10
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TVGN | Tevogen Inc. | $37.05M | $5.69 | — |
| CRBU | Caribou Biosciences, Inc. | $36.81M | $0.34 | — |
| TIL | Instil Bio, Inc. | $36.62M | $5.40 | — |
| BKHA | Black Hawk Acquisition Corp | $35.93M | $8.65 | — |
| ELOX | Eloxx Pharmaceuticals, Inc. | $40.34M | $11.74 | — |
News headlines (Yahoo Finance, 1h cache)
Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
2026-11-17 21:05 · Yahoo
Elutia (ELUT) Q3 2026 Earnings Call Transcript
2026-11-06 17:50 · Yahoo
Elutia Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
Elutia Inc (ELUT) Q3 2026 Earnings Call Highlights: Cardiovascular Growth and NXT-41X Momentum ...
2026-11-06 05:21 · Yahoo
Elutia Reports Third Quarter 2026 Results: As Plastic Surgeons Cite Infection Risk in Every Breast Research Session During National Meeting, NXT-41x Heads to FDA This Quarter, Fully Funded Through Lau
2026-11-05 21:17 · Yahoo
Elutia to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
2026-10-22 20:05 · Yahoo
Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029
2026-10-01 20:45 · Yahoo
Elutia to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th
2026-09-10 20:05 · Yahoo
Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-02 20:05 · Yahoo
Elutia (ELUT) Q2 2026 Earnings Call Transcript
2026-08-20 20:58 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.